MACRA-economics: Nephrology in the New Health System

The purpose of this activity is to provide an overview of major initiatives and policies that impact day-to-day provision of patient care and patient care operations.  This includes the Quality Payment Program described in MACRA (Medicare Access and CHIP Reauthorization Act of 2015); potential alternative payment models including ESRD Seamless Care Organizations (ESCOs) and potential models that include non-dialysis CKD, other dialysis models, and potential models that include transplant patients; and the quality metrics that impact dialysis facility and physician evaluation and reimbursement.

Target Audience

  • Physicians
Method of Participation:

Learners will review the materials on accreditation information, target audience, learning objectives, and disclosure information; participate in the entire self-study consisting of slides and audio; complete the pre-test; complete the post-test (minimum score of 70% required; learners will only have 3 attempts to pass the post-test) and evaluation to successfully earn credit. The estimated time for completion is 1.5 hours. To receive AMA PRA Category 1 Credit(s)™, participants must receive a minimum score of 70% on the post-test.   

If you participated in the live symposium MACRA-economics: Nephrology in the New Health System on Wednesday, April 19, 2017 and claimed credit, you should not claim credit for this endured activity.

Learning Objectives

After participation in this activity, learners will be better able to:

  • Describe payment reforms enacted in MACRA
  • Evaluate the effects of payment reforms on nephrology practices as well as individual nephrologists and review alternative payment models and advanced alternative payments models, including models specific to kidney care and those more general that influence kidney care
  • Identify how quality metrics are developed and implemented, and explore their effects on the provision of care to people with kidney disease
Course summary
Available credit: 
  • 1.50 AMA PRA Category 1 Credit™
  • 1.50 Attendance
Course opens: 
11/15/2017
Course expires: 
11/15/2019
Cost:
$35.00
Rating: 
0
Faculty Disclosures:

Robert Doherty, BA
Senior Vice President, Governmental Affairs and Public Policy
American College of Physicians                     
Washington, DC
Disclosure: Has no financial relationships with commercial interest(s).

Jeffrey Berns, MD
Professor of Medicine; Associate Dean for GME
University of Pennsylvania 
Philadelphia, PA       
Disclosure: The speaker received an honoraria in the subject of CKD Anemia from Bayer; has a relationship with Amgen in the subject of CKD Anemia

Daniel Weiner, MD, MS, FNKF
Nephrologist
Tufts Medical Center
Boston, MA
Disclosure: The speaker received salary support paid to their institution Dialysis Clinic, Inc for research projects and advising in the subject of kidney disease.

Planning Committee Disclosures:

Dena Rifkin, MD, MS, FNKF
Physician
VA San Diego
La Jolla, CA
Disclosure: Has no financial relationships with commercial interest(s).

Laurence Beck, Jr., MD, PhD.
Associate Professor of Medicine
Boston University School of Medicine
Boston, MA
Disclosure: The speaker research support from Pfizer CTI, and an honoraria from UpToDate, both for the subject of membranous nephropathy.

Danielle Nathan, MA
Professional Education Director
National Kidney Foundation
New York, NY
Disclosure: Has no financial relationships with commercial interest(s).

Kathryn Troy, MPH
Professional Education Coordinator
National Kidney Foundation
New York, NY
Disclosure: Has no financial relationships with commercial interest(s).

Nathalie Harden
Director, CME
National Kidney Foundation
New York, NY
Disclosure: Has no financial relationships with commercial interest(s).

Declaration of Disclosure:

It is the policy of the National Kidney Foundation (NKF) to ensure balance, independence, objectivity, and scientific rigor in all CME/CE activities. Any individual who has control over CME/CE content is required to disclose to learners prior to the activity any relevant financial relationship(s) they may have with commercial interests supporting this activity or whose products or devices are discussed in this activity.  

If, on the basis of information disclosed, a perceived conflict exists, resolution will be achieved based on NKF's Disclosure and Conflict of Interest Policy.

Unlabeled/Investigational Use:

During their presentations, faculty may discuss an unlabeled use or an investigational use not approved for a commercial product. Each faculty member is required to disclose this information to the audience when referring to an unlabeled or investigational use.

In support of improving patient care, the National Kidney Foundation is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physicians

In support of improving patient care, the National Kidney Foundation is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

The National Kidney Foundation designates this online CME/CE for a maximum of 1.5 AMA PRA Category 1 Credit(s) TM.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Available Credit

  • 1.50 AMA PRA Category 1 Credit™
  • 1.50 Attendance

Accreditation Period

Course opens: 
11/15/2017
Course expires: 
11/15/2019

Price

Cost:
$35.00
Please login or register for a PERC account to take this course.
Disclaimer:

The faculty and National Kidney Foundation (NKF) do not recommend the use of any pharmaceutical, diagnostic test, or device outside of the labeled indications as approved by the FDA. Please refer to the official prescribing information for each product for approved indications, contraindications, and warnings.

Information contained in this NKF educational resource is based upon current data available at the time of publication. Information is intended to help clinicians become aware of new scientific findings and developments.  This NKF educational resource is not intended to set out a preferred standard of care and should not be construed as one. Neither should the information be interpreted as prescribing an exclusive course of management.

Variations in practice will inevitably and appropriately occur when clinicians take into account the needs of individual patients, available resources, and limitations unique to an institution or type of practice. Every healthcare professional making use of information in this NKF educational resource is responsible for interpreting the data as it pertains to clinical decision making in each individual patient.

Required Hardware/software

System requirements can be found here.

Contact Information:

For any questions concerning this activity, please send an email to CMEinfo@kidney.org or call NKF at 1-800-622-9010.

To view NKF privacy and confidentiality policy as it relates to CME/CE activity, please visit http://www.kidney.org/

For additional professional education resources, contact NKF at 1-800-622-9010 or visit https://www.kidney.org/professionals